Comparison Chart Intellia Therapeutics, Inc.
Equities
NTLA
US45826J1051
Biotechnology & Medical Research
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 15.60 USD | +2.56% |
|
+4.87% | +72.41% |
| Mar. 06 | Nektar Therapeutics reports inducement grants under Nasdaq Listing Rule 5635(c)(4) | RE |
| Mar. 03 | Intellia Therapeutics Presents Longer-Term Clinical Data For Lonvoguran Ziclumeran | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5d. change | Varia. Jan 1. | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| INTELLIA THERAPEUTICS, INC. | Other Biotechnology & Medical Research | +1.88% | +4.87% | +72.41% | +95.71% | -77.74% | 1.8B |  |  | |
- Stock Market
- Equities
- NTLA Stock
- Charts Intellia Therapeutics, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
